The U.S. government will pay for any vaccination program against the H1N1 swine flu, and may encourage schools to help vaccinate children, Health and Human Services Secretary Kathleen Sebelius said on Thursday.
The government is also considering buying even more antiviral drugs, including more of GlaxoSmithKline's (GSK) inhaled drug Relenza and pediatric doses of Roche AG's Tamiflu, officials told a swine flu "summit" at the National Institutes of Health.
Sebelius said plans were on track for a mid-October vaccination program, and she urged states and territories to get plans in place now. It will likely run alongside the annual seasonal flu vaccine campaign and may include schools and other non-traditional sites as vaccination centers.
"At mid-October we might have as much as 100 million doses of vaccine," HHS vaccine expert Dr. Bruce Gellin told the meeting.
My Favorite Medical Instrustment and supply company is Baxter International inc. (BAX)
Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal.
The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines.
The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies.
The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine.
It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.
Disclosure I am long Both GSK and BAX in my healthcare folio. Currently I am up 17.56% year to date.
Consumer-Goods Basic-Materials ETF'S Services Industrial-Goods Black Gold(OIL) Technology Bonds Links Financial Dividend-Increasers Emerging Markets Commodities HealthCare Inflation IRA Large Cap Shipping Utilities Cefs Small Caps Fees Monthly Dividend Reits Currency 8%+ Dividend Food Fixed Income Agricultural Precious metals Dividend Declared Insurance Earnings Miss Earnings Surprise Silver Insider Buying MLP'S Stock Splits 2 - 5% Dividend Tips For NEW Investors Banks Global etfs Aerospace Computers Index Funds Preferred Stocks New ETFS Ultrashort Etfs Asset Management Chemicals Hedged Etfs 5-8% Dividend Bio-Tech Build America Bonds ETN'S Investment Brokerage Semiconductors Steel Bad Picks Dividend Cut Mortgage Retail Special Dividend 10+++% Dividend 2 - 5% dividend Audio Podcasts Bankruptcy Diversified Investments Dividend Axed Equity Offering Natural Gas Office